tmc207
Showing 1 - 12 of 12
Tuberculosis, HIV Trial in United States (Efavirenz (EFV), TMC207)
Completed
- Tuberculosis
- HIV
- Efavirenz (EFV)
- TMC207
-
San Francisco, California
- +4 more
Oct 28, 2021
Tuberculosis Trial in Lincoln (TMC207, rifapentine, rifampicin)
Completed
- Tuberculosis
- TMC207
- +2 more
-
Lincoln, NebraskaCelerion (MDS Pharma Services)
Sep 4, 2019
Tuberculosis Trial in Lithuania, Russian Federation (TMC207)
Approved for marketing
- Tuberculosis
- TMC207
-
Vilnius, Lithuania
- +4 more
Nov 23, 2017
Tuberculosis Trial in Cleveland (Rifabutin, Rifampin, TMC207)
Completed
- Tuberculosis
- Rifabutin
- +2 more
-
Cleveland, OhioCase Western Reserve University - Case Medical Center - Infectio
Apr 20, 2017
Pulmonary Tuberculosis Trial in Belville (TMC207, Rifafour e-275 mg)
Completed
- Pulmonary Tuberculosis
- TMC207
- Rifafour e-275 mg
-
Belville, Cape Town, South AfricaKarl Bremer Hospital
Mar 15, 2017
Pulmonary Tuberculosis Trial in Cape Town (PA-824, Pyrazinamide, TMC207)
Tuberculosis Trial in Worldwide (TMC207, Background Regimen (BR) for MDR-TB)
Completed
- Tuberculosis
- TMC207
- Background Regimen (BR) for MDR-TB
-
Beijing, China
- +26 more
Apr 8, 2015
Moderate Hepatic Impairment Trial (TMC207)
Completed
- Moderate Hepatic Impairment
- TMC207
- (no location specified)
Dec 19, 2012
Tuberculosis Trial (TMC207)
Completed
- Tuberculosis
- TMC207
- (no location specified)
Aug 14, 2012
Tuberculosis, HIV Trial (TMC207)
Completed
- Tuberculosis
- HIV
- TMC207
- (no location specified)
Aug 14, 2012